Literature DB >> 66470

Frequency of E. coli K antigens in urinary-tract infections in children.

B Kaijser, L A Hanson, U Jodal, G Lidin-Janson, J B Robbins.   

Abstract

The somatic (O) and casular (K) antigens of Escherichia coli from the urine of patients with acute pyelonephritis, acute cystitis, and asymptomatic bacteriuria, and in the faeces of healthy schoolchildren have been investigated. Typing antisera for sixteen capsular acidic polysaccharide K antigens were used, and five (numbers 1, 2, 3, 12, and 13) accounted for 70% of isolates from patients with acute pyelonephritis. These five K antigens were found to a lesser extent in the three other study groups. Thus, only a few K polysaccharides are associated with virulent properties of E. coli for the upper urinary tract. This finding is similar to the association of only some capsular types of pneumococci, meningococci, and Haemophilus influenzae with invasiveness. The identification of virulence markers for E. coli associated with upper-urinary-tract disease may permit more successful control with reference to preventive immunisation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66470     DOI: 10.1016/s0140-6736(77)92111-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

1.  N-acetyl-D-neuraminic acid lyase generates the sialic acid for colominic acid biosynthesis in Escherichia coli K1.

Authors:  M A Ferrero; A Reglero; M Fernandez-Lopez; R Ordas; L B Rodriguez-Aparicio
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Genetic relationships among Escherichia coli isolates causing urinary tract infections in humans and animals.

Authors:  T S Whittam; M L Wolfe; R A Wilson
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

3.  Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).

Authors:  Y Arakawa; M Ohta; R Wacharotayankun; M Mori; N Kido; H Ito; T Komatsu; T Sugiyama; N Kato
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Sequence and expression of the Escherichia coli K1 neuC gene product.

Authors:  G Zapata; J M Crowley; W F Vann
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

Review 5.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

6.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

7.  The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.

Authors:  György Schneider; Ulrich Dobrindt; Holger Brüggemann; Gábor Nagy; Britta Janke; Gabriele Blum-Oehler; Carmen Buchrieser; Gerhard Gottschalk; Levente Emödy; Jörg Hacker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Physicochemical surface properties of Escherichia coli strains isolated from different types of urinary tract infections.

Authors:  L Ohman; B Normann; O Stendahl
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

10.  Structure of the Escherichia coli K2 capsular antigen, a teichoic acid-like polymer.

Authors:  K Jann; B Jann; M A Schmidt; W F Vann
Journal:  J Bacteriol       Date:  1980-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.